Health Care Equipment(IN00304.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Health Care Equipment
IN00304.US
News
View More

Crypto PAC surges past 2024 funds at $193M as industry aims to reshape Congress

Pro-crypto political action committee Fairshake and its affiliates have over $193 million in cash for the 2026 midterms, nearly $60 million more than their 2024 spending. This indicates the industry's intent to significantly influence the upcoming House and Senate elections.

MSN·
US
GSOL
-1.17%
US
BSOL
-0.83%
US
HSDT
-1.64%
MSN·
US
GSOL
-1.17%
US
BSOL
-0.83%
US
HSDT
-1.64%

The Analyst Verdict: Becton Dickinson In The Eyes Of 7 Experts

In the latest quarter, 7 analysts provided mixed ratings for Becton Dickinson (NYSE:BDX), with an average 12-month price target of $205.57, reflecting a 2.78% increase from the previous target. Analysts have raised or lowered their ratings based on market conditions, with notable changes from firms like Piper Sandler and Stifel. Becton Dickinson, a leading manufacturer of medical products, shows strong revenue growth of 8.35% but faces challenges in return on equity and assets. The company's debt-to-equity ratio is below the industry average, indicating a conservative financial approach.

benzinga_article·
US
IHI
-0.50%
US
BDX
-0.79%
US
XHE
-0.54%
benzinga_article·
US
IHI
-0.50%
US
BDX
-0.79%
US
XHE
-0.54%

Expert Outlook: Zimmer Biomet Holdings Through The Eyes Of 13 Analysts

Thirteen analysts have recently rated Zimmer Biomet Holdings (NYSE:ZBH), revealing a mix of bullish and bearish sentiments. The average 12-month price target is $101.08, down 3.94% from previous estimates. Key analysts have adjusted their ratings, with some lowering targets and others raising them. The company's market capitalization is below industry averages, but it shows strong profitability with a net margin of 11.54%. However, its return on equity and assets are below industry benchmarks, indicating potential challenges in capital efficiency. Zimmer Biomet specializes in orthopedic reconstructive implants and surgical equipment.

benzinga_article·
US
ZBH
-0.37%
benzinga_article·
US
ZBH
-0.37%

FDA Approves Glaukos Labeling Supplement Allowing iDose TR Re-Administration

Glaukos Corporation has received FDA approval for a labeling supplement to its iDose® TR product, allowing for re-administration under a repeat treatment protocol. This decision is supported by clinical evidence demonstrating the safety and tolerability of repeated use, provided patients maintain a healthy cornea. Physicians can now administer iDose TR multiple times, as confirmed by clinical studies. This news is for informational purposes only and should not be considered financial or legal advice.

Reuters·
US
GKOS
+5.49%
Reuters·
US
GKOS
+5.49%

Solana's daily active validators have fallen below 800, a decrease of over 65% from its peak in 2023.

Solana's daily active validators have dropped below 800, a decline of over 65% from early 2023's peak of around 2,500. This reduction returns the count to 2021 levels, with validator voting transactions decreasing by 40% to 170,000 per day. The decline is attributed to changing economics, including reduced returns from the Solana Foundation Delegation Program. However, non-voting transactions remain stable at about 100 million daily.

CoinLive·
US
TSOL
0.00%
US
VSOL
-0.72%
US
SOLZ
-1.06%
CoinLive·
US
TSOL
0.00%
US
VSOL
-0.72%
US
SOLZ
-1.06%
Posts
View More

$Intuitive Surgical(ISRG.US) not confirming today. I will keep it on watch.

Source: Sunrise Trader

$Intuitive Surgical(ISRG.US) Earnings were this morning with a beat. Price is basing at a former ER gap and a variety of ma's. On watch for signs of reversal. None yet. On watch and I have to see t...

  • 0

$Boston Scientific(BSX.US) the last rung of the let it rides stop hit made some coin. The name goes back on go-to list

Source: Sunrise Trader

$Boston Scientific(BSX.US) a rung of the let it rides sold today for good $. I still own some with stops in the machine to make some coin.

Source: Sunrise Trader

$Medtronic(MDT.US) no green to red stop hit made a $1.50 a share profit. The name goes back on go-to list

Source: Sunrise Trader

© 2026 Longbridge｜Disclaimer